Data Sheet 1_Mental health professionals’ perspective on the use of esketamine in treatmen

A Saudi cross-sectional study of 223 psychiatrists and trainees explores their perspectives on esketamine for treatment-resistant depression. The dataset includes survey responses on prescribing behavior, perceived barriers, adverse effects, and motivational factors using the Physician-Motivation Adoption Scale. The data was collected via a convenience sampling method and published by Ahmad H. Almadani.

Use Cases

• Modeling factors influencing physician adoption of new treatments based on demographic and practice variables mentioned in the description.
• Analyzing perceived barriers to prescription, such as administration process and cost, across different regions and seniority levels.
• Investigating the association between concerns about side effects, like dissociation or dizziness, and prescribing hesitancy.

Strengths

• Includes responses from 223 participants, providing a specific sample size.
• Contains results from a validated instrument, the Physician-Motivation Adoption Scale.
• Reports specific statistical associations, such as the link between consultant-level practice and prescription (p = 0.003).

Limitations

• Row count for the underlying data is unknown, which may limit suitability assessment.
• Column-level documentation is absent; field semantics must be inferred after download.
• Data may reflect geographic and sampling bias inherent to a single-country, convenience-sampled study.

Provenance

Source

figshare

Collection Method

Cross-sectional study using a convenience sampling method and a researcher-developed questionnaire.

Freshness

Last updated 2026-03-18 07:37:41; freshness should be verified.

Geography

Saudi Arabia